Open Access<p>Recurrent Metastatic Penile Cancer Patient with Positive PD-L1 Expression Obtained Significant Benefit from Immunotherapy: A Case Report and Literature Review</p>
Author(s) -
Xiangyu Su,
Jing Zhang,
Chenchun Fu,
Mingzhe Xiao,
Cailian Wang
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s231258
Subject(s) - immunotherapy , medicine , oncology , biomarker , pd l1 , clinical trial , cancer , biology , biochemistry
Penile squamous cell carcinoma (PSCC) bears poor prognosis due to its rarity and limited treatment options, especially after failure of standard treatments. Effective therapeutic options were desperately needed.